Cryopraxis is committed to health.
Stockholders have been in health care and pharmaceutical industry for more than 25 years.
Cryopraxis’ project dates back to 1996 when a group of scientists decided to develop stem cell expansion protocols. At that time and since then, there have been growing data as to the potential of stem cells in the field of regenerative medicine. Validated protocols were developed and implemented as to:
- Collection
- Transportation
- Processing
- Quality Control Analysis
- Freezing
- Extreme Low Temperature Long Time Storage
- Thawing
- Management & CRM
Thawing means “defrosting” and assuring the sample will furnish viable cells. |